Ziprasidone for drug-induced psychotic symptoms in Parkinson's Disease

Progress in Neuro-Psychopharmacology and Biological Psychiatry

Volumn 32, Issue 2, 2008, Pages 583-584

  Duggal, Harpreet S ^a   Singh, Ira ^b  

^a Herrick Medical Center   (United States)

^b UNIVERSITY OF TOLEDO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARBIDOPA PLUS LEVODOPA; QUETIAPINE; ZIPRASIDONE;

ADULT; AGITATION; AUDITORY HALLUCINATION; CASE REPORT; CLINICAL FEATURE; DISORIENTATION; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; DRUG WITHDRAWAL; FEMALE; HALLUCINATION; HUMAN; LABORATORY TEST; LETTER; MENTAL HEALTH; MINI MENTAL STATE EXAMINATION; NUCLEAR MAGNETIC RESONANCE IMAGING; PARKINSON DISEASE; PERSECUTORY DELUSION; PSYCHOSIS; SCORING SYSTEM; SOMATIC DELUSION; VISUAL HALLUCINATION;

ACUTE DISEASE; ANTIPSYCHOTIC AGENTS; BRIEF PSYCHIATRIC RATING SCALE; CARBIDOPA; DRUG COMBINATIONS; HUMANS; LEVODOPA; MALE; MIDDLE AGED; PARKINSON DISEASE; PIPERAZINES; PSYCHOSES, SUBSTANCE-INDUCED; THIAZOLES;

EID: 38749099086     PISSN: 02785846     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pnpbp.2007.10.007     Document Type: Letter

References (10)

1. Breier A., Sutton V.K., Feldman P.D., et al. Olanzapine in the treatment of dopamimetic-induced psychosis in patients with Parkinson's disease. Biol Psychiatry 52 (2002) 438-445
2. Connemann B.J., and Schönfeldt-Lecuona C. Ziprasidone in Parkinson's disease psychosis. Can J Psychiatry 49 (2004) 73
3. Gómez-Esteban J.C., Zarranz J.J., Velasco F., et al. Use of ziprasidone in Parkinsonian patients with psychosis. Clin Neuropharmacol 28 (2005) 111-114
4. Kurlan R., Cummings J., Raman R., et al. Quetiapine for agitation or psychosis in patients with dementia and parkinsonism. Neurology 68 (2007) 1356-1363
5. Marsh L. Psychosis in Parkinson's disease. Prim Psychiatry 12 (2005) 56-62
6. Oechsner M., and Korchounov A. Parenteral ziprasidone: a new atypical neuroleptic for emergency treatment of psychosis in Parkinson's disease?. Hum Psychopharmacol Clin Exp 20 (2005) 203-205
7. Reddy S., Factor S.A., Molho E.S., and Feustel P.J. The effect of quetiapine on psychosis and motor function in Parkinsonian patients with and without dementia. Mov Disord 17 (2002) 676-681
8. Schindehütte J., and Trenkwalder C. Treatment of drug-induced psychosis in Parkinson's disease with ziprasidone can induce severe dose-dependent off-periods and pathological laughing. Clin Neurol Neurosurg 109 (2007) 188-191
9. Shiah I.S., Lin C.L., Mao W.C., and Luu S.U. Ziprasidone in the treatment of Parkinson's disease psychosis. Eur Psychiatr 21 (2006) 578-579
10. The Parkinson Study Group. Low-dose clozapine for the treatment of drug-induced psychosis in Parkinson's disease. N Eng J Med 340 (1999) 757-763